Calcium

Rehydrating Rose Bowl Runners: Electrolit Activates for 2024 as Official Partner of SoCal's Major Marathon Events

Retrieved on: 
Friday, January 19, 2024

HOUSTON, Jan. 19, 2024 /PRNewswire/ -- Electrolit – the preferred, premium hydration beverage made from pharmaceutical quality grade ingredients – returns with a new multiyear partnership with The McCourt Foundation, becoming the official hydration sponsor for some of Southern California's most iconic races. The season kicks off with the Rose Bowl Half Marathon and 5k on January 21, 2024, and includes the Los Angeles Marathon in March.

Key Points: 
  • Electrolit kicks off LA's first marquee race of 2024 with premium hydration at the iconic Rose Bowl Half Marathon & 5k.
  • The season kicks off with the Rose Bowl Half Marathon and 5k on January 21, 2024, and includes the Los Angeles Marathon in March.
  • "Fueling the fire at SoCal's running community – that's what Electrolit is all about," said Jake Sloan, Sr. Marketing Director.
  • The picturesque course of the Rose Bowl Half Marathon & 5K guides participants through Pasadena, highlighting landmarks such as the Colorado Street Bridge, Old Town Pasadena, and Cal Tech University.

U.S. Food and Drug Administration Grants Full Approval for BALVERSA® to Treat Locally Advanced or Metastatic Bladder Cancer with Select Genetic Alterations

Retrieved on: 
Friday, January 19, 2024

RARITAN, N.J., Jan. 19, 2024 /PRNewswire/ -- Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for BALVERSA® (erdafitinib) for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC) with susceptible fibroblast growth factor receptor 3 (FGFR3) genetic alterations whose disease has progressed on or after at least one line of prior systemic therapy. BALVERSA® is not recommended for the treatment of patients who are eligible for and have not received prior PD-1 or PD-L1 inhibitor therapy. This FDA action converts the April 2019 accelerated approval of BALVERSA® to a full approval based on the clinical and overall survival benefit observed in the Phase 3 THOR study. BALVERSA® is the first oral FGFR kinase inhibitor to be approved, and the first and only targeted treatment for patients with mUC and FGFR alterations.

Key Points: 
  • BALVERSA® is not recommended for the treatment of patients who are eligible for and have not received prior PD-1 or PD-L1 inhibitor therapy.
  • This FDA action converts the April 2019 accelerated approval of BALVERSA® to a full approval based on the clinical and overall survival benefit observed in the Phase 3 THOR study.
  • BALVERSA® is the first oral FGFR kinase inhibitor to be approved, and the first and only targeted treatment for patients with mUC and FGFR alterations.
  • This model is part of the Company's ongoing commitment to provide high-quality products, services, access, and support to healthcare professionals and patients.

Suja Organic Launches Ready-To-Drink Protein Beverages

Retrieved on: 
Thursday, January 11, 2024

Suja Organic , the leader in cold-pressed, organic beverages, announced today the launch of Suja Organic Protein Shakes, a new line of elevated ready-to-drink (RTD) protein.

Key Points: 
  • Suja Organic , the leader in cold-pressed, organic beverages, announced today the launch of Suja Organic Protein Shakes, a new line of elevated ready-to-drink (RTD) protein.
  • With the introduction of Suja Organic Protein Shakes, the company aims to further its purpose by providing customers with a healthy, convenient beverage as part of a well-balanced diet.
  • “To further establish Suja Organic as a wellness platform with offerings that meet essential daily nutrition, we’re thrilled to introduce our new protein shakes,” said Bryan Riblett, Chief Innovation Officer at Suja Organic.
  • “Our customers already look to Suja Organic for their nutrition needs and these new protein blends have been meticulously crafted to include protein, vitamins, minerals and fiber for the perfect balance of function and nutrition.

Tayloáni, Curls Dynasty, and Fitglow Beauty Are Winners for Most Innovative Products 2024

Retrieved on: 
Thursday, January 11, 2024

NEW YORK, Jan. 11, 2024 /PRNewswire/ -- Taylonáni: Discover the science of hair transformation

Key Points: 
  • Tayloáni presents an elegant thinning hair care line of products uniquely designed for pregnant women and new mothers.
  • Excited and passionate to share her discoveries, Curls Dynasty was born, offering natural products for natural hair.
  • Fitglow Beauty developed by Anna Domi, emerged after she found out that her own skin was sensitive to harsh synthetic products.
  • Skin and Beauty Journal is a digital publication serving an audience located primarily in the United States.

Silk Kicks Off Feel Planty Good Challenge with Star-Powered Smoothies, Inviting People to Commit to 7 Days of 7 Delicious Plant-Based Breakfasts for a Chance to Win Free Breakfast for Life

Retrieved on: 
Wednesday, January 10, 2024

BROOMFIELD, Colo., Jan. 10, 2024 /PRNewswire/ -- It's mid-January, so let's get real: how are those New Year's resolutions going? We all know how difficult it can be to stick to a healthy routine – in fact, only 25 percent of people find it really easy to incorporate nutritious foods into their diets.1 Enter Silk, America's #1 plant-based brand and a big believer in the power of plant-based nutrition.2  

Key Points: 
  • To join the challenge, simply pledge to incorporating Silk into your breakfast for seven days in a row this January and enter to win on Challenge.Silk.com for a chance to win free breakfast for life.
  • Head to Challenge.Silk.com to join the Silk Feel Planty Good Challenge and download the Feel Planty Good Challenge recipe list and a Silk coupon to kickstart your journey.
  • For more recipe inspiration to make sure you keep feeling planty good, check out @LoveMySilk on TikTok and @Silk on Instagram .
  • For a chance to be featured on Silk channels, share your favorite Silk breakfast on TikTok and Instagram by tagging Silk and using #FeelPlantyGood.

Mastering Nugget Ice Maker Maintenance: VIVIDMOO® Launched Comprehensive Guide to Cleaning and Care for Sonic and Chewable Ice Machines

Retrieved on: 
Wednesday, January 10, 2024

This guide will help customer maintain their ice maker effectively, in line with VIVIDMOO®'s commitment to quality and healthy usage.

Key Points: 
  • This guide will help customer maintain their ice maker effectively, in line with VIVIDMOO®'s commitment to quality and healthy usage.
  • To keep the nugget, sonic, or chewable ice maker in top condition, routine cleaning is essential.
  • Plug in the Nugget ice maker, press and hold the "Clean" button for 5 seconds to initiate the 15-minute cleaning process.
  • Regular cleaning not only extends the lifespan of the Opal Nugget Ice Maker but also ensures the quality of the ice it produces.

The Laughing Cow® Launches Plant-Based Spreadable Cheese Alternative at Whole Foods

Retrieved on: 
Tuesday, January 9, 2024

CHICAGO, Jan. 9, 2024 /PRNewswire/ -- The Laughing Cow®, known for its spreadable, creamy cheese wedges, is starting off the new year on a plant-based note by launching its highly-anticipated dairy-free iteration, The Laughing Cow Plant-Based in Garlic & Herb, now on shelves at Whole Foods nationwide.

Key Points: 
  • CHICAGO, Jan. 9, 2024 /PRNewswire/ -- The Laughing Cow® , known for its spreadable, creamy cheese wedges, is starting off the new year on a plant-based note by launching its highly-anticipated dairy-free iteration, The Laughing Cow Plant-Based in Garlic & Herb, now on shelves at Whole Foods nationwide.
  • The vegan-certified cheese alternative comes in the same individually portioned wedges The Laughing Cow fans know and love.
  • Snackers can enjoy The Laughing Cow Plant-Based in endless combinations – like spread on a bagel, dipped with veggies, or scooped with crackers.
  • In addition to its fan-favorite creamy texture, The Laughing Cow Plant-Based is also a good source of calcium and is non-GMO certified.

EQS-News: Immunic Highlights 2023 Accomplishments and Upcoming Milestones

Retrieved on: 
Friday, January 5, 2024

“With vidofludimus calcium (IMU-838) and IMU-856, we have two development programs beyond clinical proof-of-concept which is an outstanding achievement of our entire team.

Key Points: 
  • “With vidofludimus calcium (IMU-838) and IMU-856, we have two development programs beyond clinical proof-of-concept which is an outstanding achievement of our entire team.
  • A more thorough review of recent events and upcoming milestones follows:
    Announced a three-tranche private placement of up to $240 million with participation from select new and existing investors today.
  • Immunic believes that this data illustrates biomarker evidence that vidofludimus calcium’s activity extends beyond the previously observed anti-inflammatory effects, further reinforcing its neuroprotective potential.
  • Immunic believes this data provides initial clinical proof-of-concept for an entirely new therapeutic approach to gastrointestinal disorders by promoting regeneration of bowel architecture.

Immunic Highlights 2023 Accomplishments and Upcoming Milestones

Retrieved on: 
Friday, January 5, 2024

"With vidofludimus calcium (IMU-838) and IMU-856, we have two development programs beyond clinical proof-of-concept which is an outstanding achievement of our entire team.

Key Points: 
  • "With vidofludimus calcium (IMU-838) and IMU-856, we have two development programs beyond clinical proof-of-concept which is an outstanding achievement of our entire team.
  • A more thorough review of recent events and upcoming milestones follows:
    Announced a three-tranche private placement of up to $240 million with participation from select new and existing investors today.
  • Immunic believes that this data illustrates biomarker evidence that vidofludimus calcium's activity extends beyond the previously observed anti-inflammatory effects, further reinforcing its neuroprotective potential.
  • Immunic believes this data provides initial clinical proof-of-concept for an entirely new therapeutic approach to gastrointestinal disorders by promoting regeneration of bowel architecture.

Healthy Extracts Launches First Anti-Aging Formulation, LONGEVITY

Retrieved on: 
Thursday, January 4, 2024

In celebration of the launch, for a limited time you can buy two and get one free .

Key Points: 
  • In celebration of the launch, for a limited time you can buy two and get one free .
  • “LONGEVITY Anti-Aging complements our growing heart health product portfolio which supports a holistic approach to anti-aging like healthy skin,” noted Healthy Extracts president, Duke Pitts.
  • LONGEVITY Anti-Aging is your ally for overall longevity, blending ingredients renowned for their anti-aging benefits that support a longer, healthier life.
  • To learn more about Healthy Extracts’ full line of clinically-backed, natural brain and hearth health products, go to bergametna.com or tryubn.com .